Alix Ashare MD
Critical Care Medicine, Pleural Disease
Assistant Professor, Medicine, Geisel School of Medicine
Join to view full profile
1 Medical Center DriveLebanon, NH 03756
Phone+1 603-650-5533
Fax+1 603-640-1911
Dr. Ashare is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Iowa Health Care Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005- University of Iowa Health Care Medical CenterResidency, Internal Medicine, 1999 - 2002
Vanderbilt University School of MedicineClass of 1999
Certifications & Licensure
NH State Medical License 2009 - 2027
VT State Medical License 2022 - 2026
IA State Medical License 1999 - 2010
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)
- Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung
- Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment
Publications & Presentations
PubMed
- Polymicrobial Extracellular Vesicles Reduce the Innate Immune Response of Human Cystic Fibrosis Bronchial Epithelial Cells.Lily A Charpentier, Roxanna L Barnaby, Carolyn T Roche, Byoung-Kyu Cho, Prashant Kaushal
Journal of Extracellular Biology. 2026-08-01 - Human mesenchymal stromal cell extracellular vesicles maintain therapeutic miRNA cargo despite exposure to cystic fibrosis bronchoalveolar lavage fluid.Sara Rolandsson Enes, Thomas H Hampton, Jayita Barua, Zeta Mui, Tobias Tertel
Cytotherapy. 2026-06-20 - mutants resist phagocytosis and alter inflammatory cytokine production by cystic fibrosis macrophages.Daniel S Aridgides, Diane L Mellinger, Lorraine L Gwilt, Anthony R Correia, Carson E Finger
Msphere. 2026-04-28
Journal Articles
- Evolution of Drug Resistance in an Antifungal-Naive Chronic Candida Lusitaniae InfectionAlix Ashare, MD, Proceedings of the National Academy of Sciences
Grant Support
- Mechanisms of Impaired Inflammation Resolution in Cystic Fibrosis Lung DiseaseDARTMOUTH-HITCHCOCK CLINIC2024–2028
- Mechanisms of Impaired Inflammation Resolution in Cystic Fibrosis Lung DiseaseDARTMOUTH-HITCHCOCK CLINIC2024–2028
- Macrophage Pathogen Interactions in Regional Cystic Fibrosis Lung InflammationDARTMOUTH-HITCHCOCK CLINIC2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
